Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,318 Cr
down ₹124 Cr vs Dec 2021
- Stocks held
- 24
- unchanged
- Top 10 weight
- 68.4%
- of the portfolio in its ten largest
- Cash & debt
- −0.1%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 5, trimmed 18
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In January 2022 it disclosed 24 stocks worth ₹1,318 Cr, down ₹124 Cr from Dec 2021. Its largest positions were Sun Pharmaceutical Industries Limited (12.9%), Cipla Limited (8.7%), Max Healthcare Institute Limited (7.9%); the ten largest together made up 68.4% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 54.0% of its equity. Cash and debt stood at −0.1%. Compared with Dec 2021 the fund entered 0 new stocks and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
7%
Holds more stocks than 7% of peers
Cash
0%
Holds more cash than 0% of peers
What these mean: concentration · cash
Holdings in January 2022
Download CSVEvery line the fund disclosed, with the change against Dec 2021. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 12.88% | up 0.95 pts | ₹170 Cr | down ₹2.3 Cr | Trimmed |
| Cipla Limited | 8.72% | up 0.76 pts | ₹115 Cr | up ₹11 L | Held |
| Max Healthcare Institute Limited | 7.86% | down 0.80 pts | ₹104 Cr | down ₹21.3 Cr | Trimmed |
| Apollo Hospitals Enterprise Limited | 6.71% | down 0.19 pts | ₹88.4 Cr | down ₹11 Cr | Trimmed |
| IPCA Laboratories Limited | 6.20% | up 0.27 pts | ₹81.7 Cr | down ₹3.8 Cr | Trimmed |
| Procter & Gamble Health Limited | 6.09% | up 0.22 pts | ₹80.3 Cr | down ₹4.4 Cr | Trimmed |
| Lupin Limited | 5.92% | up 0.26 pts | ₹78 Cr | down ₹3.7 Cr | Trimmed |
| Dr. Reddy's Laboratories Limited | 5.47% | down 0.23 pts | ₹72 Cr | down ₹10.1 Cr | Trimmed |
| Alkem Laboratories Limited | 4.51% | up 0.29 pts | ₹59.5 Cr | down ₹1.4 Cr | Trimmed |
| Vijaya Diagnostic Centre Limited | 3.99% | down 0.12 pts | ₹52.6 Cr | down ₹6.7 Cr | Trimmed |
| Indoco Remedies Limited | 3.29% | down 0.25 pts | ₹43.3 Cr | down ₹7.7 Cr | Trimmed |
| Narayana Hrudayalaya Limited | 3.10% | up 0.29 pts | ₹40.8 Cr | up ₹37 L | Added |
| Intuitive Surgical Inc | 2.96% | down 0.55 pts | ₹39 Cr | down ₹11.7 Cr | Trimmed |
| ICICI Lombard General Insurance Company Limited | 2.51% | up 0.16 pts | ₹33.1 Cr | down ₹78 L | Trimmed |
| Globus Medical Inc | 2.48% | down 0.03 pts | ₹32.6 Cr | down ₹3.5 Cr | Trimmed |
| Abbott Laboratories | 2.27% | down 0.04 pts | ₹29.9 Cr | down ₹3.3 Cr | Trimmed |
| Abiomed Inc | 2.19% | down 0.30 pts | ₹28.9 Cr | down ₹7 Cr | Trimmed |
| Syngene International Limited | 2.01% | up 0.01 pts | ₹26.5 Cr | down ₹2.3 Cr | Trimmed |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.80% | up 1.36 pts | ₹23.8 Cr | up ₹17.4 Cr | Added |
| Aarti Drugs Limited | 1.79% | up 0.02 pts | ₹23.5 Cr | down ₹1.9 Cr | Trimmed |
| Illumina Inc | 1.61% | up 1.13 pts | ₹21.2 Cr | up ₹14.4 Cr | Added |
| MedPlus Health Services Limited | 1.58% | up 0.20 pts | ₹20.9 Cr | up ₹93 L | Added |
| Alembic Pharmaceuticals Limited | 1.56% | up 0.05 pts | ₹20.5 Cr | down ₹1.2 Cr | Trimmed |
| Unichem Laboratories Limited | 1.33% | up 0.19 pts | ₹17.5 Cr | up ₹1.2 Cr | Added |
| Kovai Medical Center and Hospital Limited | 1.32% | up 0.15 pts | ₹17.4 Cr | up ₹55 L | Added |
| Cash, TREPS & receivables | −0.14% | down 3.81 pts | −₹1.8 Cr | down ₹54.7 Cr | Trimmed |
What changed, Dec 2021 to Jan 2022
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Illumina Incup ₹14.4 Cr (+1.13% pts)
- Unichem Laboratories Limitedup ₹1.2 Cr (+0.19% pts)
- MedPlus Health Services Limitedup ₹93 L (+0.20% pts)
- Kovai Medical Center and Hospital Limitedup ₹55 L (+0.15% pts)
- Narayana Hrudayalaya Limited ₹37 L (+0.29% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Dec 2021, the weight rose most in Pharmaceuticals & Biotechnology (+1.3 pts) and Retailing (+0.2 pts), and fell most in Healthcare Equipment & Supplies (−0.7 pts) and Healthcare Services (−0.6 pts).
- Pharmaceuticals & Biotechnology52.7% → 54.0%+1.3 pts
- Retailing1.4% → 1.6%+0.2 pts
- Insurance2.4% → 2.6%+0.1 pts
- Healthcare Equipment & Supplies6.3% → 5.5%−0.7 pts
- Healthcare Services29.8% → 29.3%−0.6 pts
- Pharmaceuticals7.3% → 7.0%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Jan 2019 | Jan 2021 | Jul 2021 | Oct 2021 | Dec 2021 | Jan 2022 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 72.9% | 65.4% | 60.8% | 58.7% | 52.7% | 54.0% |
| Healthcare Services | 14.7% | 21.1% | 23.3% | 25.4% | 29.8% | 29.3% |
| Pharmaceuticals | 10.0% | 7.1% | 7.2% | 7.0% | 7.3% | 7.0% |
| Healthcare Equipment & Supplies | — | 3.3% | 6.2% | 6.3% | 6.3% | 5.5% |
| Insurance | 2.4% | 3.1% | 2.5% | 2.5% | 2.4% | 2.6% |
| Retailing | — | — | — | — | 1.4% | 1.6% |
Allocation in Jan 2022change vs Dec 2021
- Pharmaceuticals & Biotechnology (9)54.0%▲ 1.3 pts
- Healthcare Services (8)29.3%▼ 0.6 pts
- Pharmaceuticals (3)7.0%▼ 0.3 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Jan 2022
−0.1%
▼ 3.8 pts vs Dec 2021
- Cash alone
- −0.1%
- cash and net receivables
- A year earlier
- 2.4%
- Jan 2021 · now ▼ 2.6 pts
- Last 12 months
- −0.3% – 6.4%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.